3 Reasons to Buy BioAge Labs Stock Hand Over Fist in October
BioAge Labs (NASDAQ: BIOA) is a biotech company that you may be hearing a lot about over the coming years. Dedicated to developing medicines for closely linked problems like metabolic disorders and aging, BioAge has candidates that are, so far, not directly comparable to anything